Utility of Adding Platelet-Rich Plasma to Microneedling vs Microneedling Alone in the Treatment of Acne Scarring

January 2025 | Volume 24 | Issue 1 | 41 | Copyright © January 2025


Published online December 16, 2024

doi:10.36849/JDD.8585R1

Rama Abdin BSa, Simonetta I. Gaumond MSb, Marita Yaghi MDb, Rami H. Mahmoud BSb, Mario Rodriguez MSb, Naiem T. Issa MD PhDb,c,d,e, Joaquin J. Jimenez MDb

aCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL
bDr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL
cForefront Dermatology, Vienna, VA
dIssa Research and Consulting, LLC, Springfield, VA
eThe George Washington University School of Medicine and Health Sciences, Washington, DC

Abstract
Acne vulgaris is one of the most common skin diseases worldwide and affects a large population of patients. Post-acne scarring can pose a significant psychosocial burden on patients of all ages; therefore, treatment approaches must be both rapid-acting and effective. Microneedling is a minimally invasive technology that involves the creation of controlled tissue microinjury and subsequent induction of collagen production and tissue remodeling. Platelet-rich plasma (PRP) is an autologous preparation of plasma containing supraphysiologic concentrations of platelets, growth factors, and cytokines. The combination of microneedling and PRP therapy has been postulated to offer synergistic effects in the treatment of acne scarring. The purpose of this review is to critically analyze recent clinical trials that compare the efficacy of microneedling monotherapy to the combination of PRP and microneedling for the treatment of atrophic acne scarring.

J Drugs Dermatol. 2025;24(1):41-46. doi:10.36849/JDD.8585R1

INTRODUCTION

Acne vulgaris is a very common cutaneous disorder with a multifactorial etiology. The development of acne vulgaris involves increased sebum production, follicular hyperkeratinization, Cutibacterium acnes colonization, and upregulated inflammatory responses.1 The inflammatory destruction created by acne vulgaris can leave behind atrophic acne scarring, posing a significant negative psychosocial impact on patients.1,2 Atrophic acne scarring can be classified into 3 main types: rolling, boxcar, and icepick scars. Patients can present with 1, 2, or all 3 scar types, therefore, an in-depth and nuanced evaluation of patients is imperative to pursue appropriate therapeutics.1 Microneedling involves the creation of multiple microchannels within the skin that physically disrupt the dysregulated collagen bundles present within the superficial layer of the dermis of acne scars, and promotes the production of new collagen and elastin beneath the scars.3 This controlled tissue microinjury triggers a cascade of wound healing events involving the release of multiple growth factors, including but not limited to platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and transforming growth factor (TGF)- alpha and beta. Microneedling-induced fibroblast proliferation fosters the deposition of type 3, and ultimately type 1, collagen in an organized pattern.3 There are multiple microneedling devices present on the market, which vary based on needle length, diameter, material, and quantity. The optimal parameters for microneedling have not been well defined and likely vary based on the targeted disease process.3 Platelet-rich plasma (PRP) is an autologous preparation of plasma that contains a supraphysiologic concentration of platelets. Upon activation, the alpha-granules of platelets release high concentrations of growth factors such as TGF-β, PDGF, vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), and other chemokines and cytokines, which aid in cell differentiation, proliferation, and regeneration.4 Thus, the combination of PRP and microneedling has been postulated to provide synergistic benefits to patients as the application of PRP following microneedling allows for deeper penetration of the agent and, thus, rapid-acting and effective treatment.

MATERIALS AND METHODS

A literature search was performed on PubMed in January 2024 using a combination of the keywords "platelet-rich plasma," "microneedling," "needling," "acne scarring," and "acne scar." We included published clinical trials from 2018 to January 2024, which included a comparison of the efficacy of combination PRP and microneedling and microneedling alone in more than 2 patients. In-vitro studies, animal trials, non-English articles, and studies that did not directly compare combination and monotherapy were excluded. Overall, 6 studies were rigorously reviewed and summarized (Table 1).